Surfactant Protein A Impairs Genital HPV16 Pseudovirus Infection by Innate Immune Cell Activation in A Murine Model (2019)
Attributed to:
Development of recombinant surfactant protein D therapy to prevent neonatal chronic lung disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/pathogens8040288
PubMed Identifier: 31817644
Publication URI: http://europepmc.org/abstract/MED/31817644
Type: Journal Article/Review
Parent Publication: Pathogens
Issue: 4
ISSN: 2076-0817